A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months

• Glavni autori: Wei Gu (Autor), Gang Zeng (Autor), Yue-mei Hu (Autor), Yuan-Sheng Hu (Autor), Ying Zhang (Autor), Ya-ling Hu (Autor), Yang Wang (Autor), Jing-Xin Li (Autor), Feng-Cai Zhu (Autor)
• Format: Knjiga
• Izdano: Taylor & Francis Group, 2018-03-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background: The Sinovac enterovirus 71 (EV71) vaccine has shown good safety, immunogenicity, and efficacy in infants aged 6-35 months, whom are considered as the priority of the target population. However, 3-5 years old children accounted for approximately 30% of HFMD cases and are also worth our at...